AI in Drug Discovery: Surveying the Breadth of the Challenges
AI can speed up drug discovery and decrease attrition rates in the clinic, but it…
AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are those that stay grounded, set realistic expectations, and keep experienced scientists at the center of decisions that require genuine creativity and judgment. The post…
[Sponsored] A checklist for AI readiness from Nordic aims to help healthcare organizations avoid failure. The post Is Your Healthcare Organization Ready to Implement AI? appeared first on MedCity News.
U.S. health secretary Robert F. Kennedy Jr. is pursuing federal government access to most Americans’ medical records, in a quest to research a link between vaccines and autism — a connection the medical establishment studied for decades and flatly rejects. The Department of Health and Human Services is seeking data from little-known state systems that…
Yolibeth’s 4-year-old daughter scrambled headfirst onto a cushy leather love seat at their home near New Orleans and pushed a hairbrush into the hands of Miriam Romero, a health coordinator who works with the family. Romero placed the girl in her lap and started brushing her dark hair. Yolibeth, a 38-year-old single mother who moved…
By MATTHEW ZACHARY The American healthcare system behaves exactly as its incentives tell it to behave. That sentence sounds almost boring until you follow it to its logical conclusion. Insurance companies now influence clinical decisions more aggressively than many physicians. They shape hospital consolidation. They determine startup viability. They influence venture capital allocation. They dictate…
Ingestible sensors are emerging as a promising frontier in gastroenterology, offering a minimally invasive way to monitor the gastrointestinal (GI) tract in real time. Instead of relying solely on endoscopy or colonoscopy—which are costly, invasive, and often avoided by patients—swallowable devices can capture biochemical signals such as gases and redox balance as they pass through…
Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology. The post Former FDA Officials: There’s Opportunity to Rebuild…
Peterson Philanthropies launched Peterson Health Analytics with a $50 million commitment to help employers better understand and manage healthcare costs. The post Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment appeared first on MedCity News.
The Trump administration’s rollout of a federal mandate that millions of Americans on Medicaid must work or risk losing health benefits will force states to scrap months of preparation, according to advocates for Medicaid enrollees and consultants advising states. And they say an overhaul — less than seven months before states must start enforcing the…
Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models. The post What Will the Next Healthcare Exit Winners Look Like? appeared first on MedCity News.